News Releases & Statements
News Releases & Statements
LLS is Committed to Advocating for Cancer Patients in Wake of Dobbs Ruling
Posted On: June 27, 2022 Read More
Another CAR T -Cell Therapy Approved for Earlier Treatment of the Most Common Type of Lymphoma
Posted On: June 24, 2022 Read More
America’s Youngest Generation is Trailblazing the Way for a Future without Cancer
Posted On: June 22, 2022 Read More
FDA Approves Immunotherapy for Aggressive Form of Follicular Lymphoma
Posted On: June 2, 2022 Read More
FDA Approves Combination Therapy for Patients with Certain Forms of Acute Myeloid Leukemia
Posted On: June 1, 2022 Read MoreMedia Requests
Please send all media-related inquiries and interview requests to mediarelations@lls.org. An LLS representative will respond as soon as possible.